These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 36251559)
1. Antitoxin Use in the Prevention and Treatment of Anthrax Disease: A Systematic Review. Hesse EM; Godfred-Cato S; Bower WA Clin Infect Dis; 2022 Oct; 75(Suppl 3):S432-S440. PubMed ID: 36251559 [TBL] [Abstract][Full Text] [Related]
2. Antitoxin Treatment of Inhalation Anthrax: A Systematic Review. Huang E; Pillai SK; Bower WA; Hendricks KA; Guarnizo JT; Hoyle JD; Gorman SE; Boyer AE; Quinn CP; Meaney-Delman D Health Secur; 2015; 13(6):365-77. PubMed ID: 26690378 [TBL] [Abstract][Full Text] [Related]
3. CDC Guidelines for the Prevention and Treatment of Anthrax, 2023. Bower WA; Yu Y; Person MK; Parker CM; Kennedy JL; Sue D; Hesse EM; Cook R; Bradley J; Bulitta JB; Karchmer AW; Ward RM; Cato SG; Stephens KC; Hendricks KA MMWR Recomm Rep; 2023 Nov; 72(6):1-47. PubMed ID: 37963097 [TBL] [Abstract][Full Text] [Related]
4. Systematic Review of Hospital Treatment Outcomes for Naturally Acquired and Bioterrorism-Related Anthrax, 1880-2018. Person MK; Cook R; Bradley JS; Hupert N; Bower WA; Hendricks K Clin Infect Dis; 2022 Oct; 75(Suppl 3):S392-S401. PubMed ID: 36251553 [TBL] [Abstract][Full Text] [Related]
12. A Review of the Efficacy of FDA-Approved Couse Z; Cui X; Li Y; Moayeri M; Leppla S; Eichacker PQ Toxins (Basel); 2021 Jan; 13(1):. PubMed ID: 33450877 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of immunogenicity and efficacy of anthrax vaccine adsorbed for postexposure prophylaxis. Ionin B; Hopkins RJ; Pleune B; Sivko GS; Reid FM; Clement KH; Rudge TL; Stark GV; Innes A; Sari S; Guina T; Howard C; Smith J; Swoboda ML; Vert-Wong E; Johnson V; Nabors GS; Skiadopoulos MH Clin Vaccine Immunol; 2013 Jul; 20(7):1016-26. PubMed ID: 23658392 [TBL] [Abstract][Full Text] [Related]
14. Clinical Framework and Medical Countermeasure Use During an Anthrax Mass-Casualty Incident. Bower WA; Hendricks K; Pillai S; Guarnizo J; Meaney-Delman D; MMWR Recomm Rep; 2015 Dec; 64(4):1-22. PubMed ID: 26632963 [TBL] [Abstract][Full Text] [Related]
15. Alternative pre-approved and novel therapies for the treatment of anthrax. Head BM; Rubinstein E; Meyers AF BMC Infect Dis; 2016 Nov; 16(1):621. PubMed ID: 27809794 [TBL] [Abstract][Full Text] [Related]
16. Does anthrax antitoxin therapy have a role in the treatment of inhalational anthrax? Vietri NJ Curr Opin Infect Dis; 2018 Jun; 31(3):257-262. PubMed ID: 29570493 [TBL] [Abstract][Full Text] [Related]
17. Obiltoxaximab: Adding to the Treatment Arsenal for Bacillus anthracis Infection. Hou AW; Morrill AM Ann Pharmacother; 2017 Oct; 51(10):908-913. PubMed ID: 28573869 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of early immune response-survival relationship in cynomolgus macaques after Anthrax Vaccine Adsorbed vaccination and Bacillus anthracis spore challenge. Sivko GS; Stark GV; Tordoff KP; Taylor KL; Glaze E; VanRaden M; Schiffer JM; Hewitt JA; Quinn CP; Nuzum EO Vaccine; 2016 Dec; 34(51):6518-6528. PubMed ID: 27155494 [TBL] [Abstract][Full Text] [Related]
19. Systematic Review of In Vitro Antimicrobial Susceptibility Testing for Bacillus anthracis, 1947-2019. Maxson T; Kongphet-Tran T; Mongkolrattanothai T; Travis T; Hendricks K; Parker C; McLaughlin HP; Bugrysheva J; Ambrosio F; Michel P; Cherney B; Lascols C; Sue D Clin Infect Dis; 2022 Oct; 75(Suppl 3):S373-S378. PubMed ID: 36251548 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of ETI-204 monoclonal antibody as an adjunct therapy in a New Zealand white rabbit partial survival model for inhalational anthrax. Biron B; Beck K; Dyer D; Mattix M; Twenhafel N; Nalca A Antimicrob Agents Chemother; 2015 Apr; 59(4):2206-14. PubMed ID: 25645849 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]